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ARTICLE
A bacterial gene-drive system efficiently edits
and inactivates a high copy number
antibiotic resistance locus
J. Andrés Valderrama1,2, Surashree S. Kulkarni1,3, Victor Nizet 1,2,4* & Ethan Bier1,3*
Gene-drive systems in diploid organisms bias the inheritance of one allele over another.
CRISPR-based gene-drive expresses a guide RNA (gRNA) into the genome at the site where
the gRNA directs Cas9-mediated cleavage. In the presence of Cas9, the gRNA cassette and
any linked cargo sequences are copied via homology-directed repair (HDR) onto the
homologous chromosome. Here, we develop an analogous CRISPR-based gene-drive system
for the bacterium Escherichia coli that efficiently copies a gRNA cassette and adjacent cargo
flanked with sequences homologous to the targeted gRNA/Cas9 cleavage site. This “pro-
active” genetic system (Pro-AG) functionally inactivates an antibiotic resistance marker on a
high copy number plasmid with ~ 100-fold greater efficiency than control CRISPR-based
methods, suggesting an amplifying positive feedback loop due to increasing gRNA dosage.
Pro-AG can likewise effectively edit large plasmids or single-copy genomic targets or
introduce functional genes, foreshadowing potential applications to biotechnology or
biomedicine.
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Synthetic gene-drive elements based on bacterial-derivedCRISPR components have been developed in diploidorganisms including yeast1, insects2–4, and mammals5. The
salient feature of these “active genetic” systems is that a guide
RNA (gRNA) is directly flanked by sequences homologous to the
genomic site it targets for Cas9-mediated cleavage. When double-
stranded DNA breaks are induced in the germline by the gRNA/
Cas9 complex, the gRNA together with any linked cargo
sequences are then copied into the break via the homology-
directed repair (HDR) pathway6. Such gene conversion events
can greatly bias transmission of the gRNA cassette so that it is
inherited by nearly all progeny.
Echoing their functional CRISPR origins, synthetic bipartite
gRNA/Cas9 systems have been developed in bacteria7–9, includ-
ing targeting of plasmid-encoded antibiotic resistance determi-
nants10. Indeed, as plasmid-borne antibiotic resistance genes and
virulence determinants are important in the pathogenesis of
many human bacterial infections, inactivation or replacement of
such multi-copy targets could greatly impact the success or failure
of treatment interventions11,12. We contemplated whether mod-
ifying a standard bacterial CRISPR system by developing an
active self-copying mechanism could enhance efforts to scrub
antibiotic resistance in prokaryotes (“pro-active genetics” or Pro-
AG) and thereby address the challenge of high gene dosage on
multi-copy plasmids.
Here, we develop a Pro-AG gene-drive system for the bacter-
ium Escherichia coli that efficiently copies a functional gRNA
cassette flanked with sequences homologous to the targeted
gRNA/Cas9 cleavage site. Pro-AG inactivates an antibiotic resis-
tance marker on a high copy number plasmid with ~ 100-fold
greater efficiency than control CRISPR-based methods, indicating
a self-amplifying positive feedback loop linked to increasing
gRNA dosage. Likewise, the system can efficiently edit a large
plasmid, target genes on the bacterial chromosome, or be adapted
to introduce functional gene cargos alongside the gRNA cassette.
Pro-AG expands the available toolkit for engineering or manip-
ulating bacteria in future biotechnology and biomedicine
applications.
Results
Establishment of the pro-active genetics (Pro-AG) system. In
our first set of experiments, we employed a set of three mutually
compatible plasmids to assess Cas9-mediated cleavage/inactiva-
tion of the beta-lactamase (bla) target gene, which confers
ampicillin resistance (AmpR) in Escherichia coli. The three plas-
mids were: (1) high copy number pET bearing the bla target gene
and conferring AmpR; (2) low copy pCRISPR Amp carrying one
of two different gRNAs targeting bla sequences under constitutive
transcriptional control and maintained under spectinomycin
selection (SpmR); and (3) low copy pCas9-expressing Cas9 under
control of a tet promoter, inducible with anhydrotetracycline
(aTc) and propagated under chloramphenicol selection (CmR)
(Fig. 1a; Supplementary Table 1).
Initial transformation of E. coli with the compatible three-
plasmid system (scheme in Supplementary Fig. 1a) did not lead to
significant differences in colony-forming unit (CFU) recovery on
triple antibiotic (Amp+ Spm+ Cm) agar plates either in the
presence (+aTc) or absence (−aTc) of anhydrotetracycline
induction with either of two different gRNAs targeting bla
sequences (Supplementary Fig. 2a). Individual E. coli colonies
carrying all three plasmids were then tested under an overnight
growth protocol that imposes multi-generational antibiotic
selection (see Supplementary Fig. 1 and Methods). In brief,
colonies inoculated in Luria broth (LB) were grown overnight,
maintaining antibiotic selection with or without aTc induction
(Supplementary Fig. 1a). Although terminal culture densities
were unaltered by Cas9 induction (Supplementary Fig. 2b),
culture aliquots regrown under the more-stringent conditions
imposed by selection on triple-antibiotic plates displayed
significant Cas9-dependent reductions in CFU for both gRNA1
(~ 10-fold) and gRNA2 (~ 100-fold) (Fig. 1b). These differential
responses to the Cas9 induction regimen are likely attributable to
non-autonomous antibiotic rescue of mixed cells by secreted Bla
in overnight liquid culture, absent during antibiotic plate
selection of well isolated colonies. This strategy using CRISPR-
Cas9 alone (e.g., without a homology template) is referred to
hereafter as CRISPR-control.
As the targeting efficiency of gRNA2 under the aforementioned
CRISPR-control framework matched previously reported reduc-
tions in CFU using a similar experimental paradigm10, we chose
to test this gRNA in a “pro-active” configuration (Pro-AG)
(Fig. 1c). We modified the SpmR gRNA-expressing plasmid by
flanking the gRNA2 expression cassette with bla sequence
homology arms (HA, ~ 500 bp each, comparable in length to
HA employed in eukaryotic systems) that directly abut the gRNA
cleavage site, generating the pPro-AG plasmid (Supplementary
Table 1). Since the gRNA cleavage site is absent from this
plasmid, the encoded gRNA is unable to cleave these sequences in
the presence of Cas9. Because standard E. coli strains do not
support efficient homology-based insertion of genomic cassettes
following induction of double-strand DNA breaks13,14, we
made use of a cassette encoding recombinogenic lambda-Red
(λRed)15,16 enzymes under control of an arabinose inducible
promoter (arab) that is also encoded on this plasmid9. Plasmids
pET (carrying the bla AmpR target gene) and pCas9 were
identical to those used for the “CRISPR- control” regimen
(Fig. 1c). Following the parallel experimental scheme depicted in
Supplementary Fig. 1b, we again observed no significant
differences in CFU following initial transformation of the three
Pro-AG plasmid components under triple-antibiotic (Amp+
Spm+ Cm) selection with or without Cas9 induction (i.e., ± aTc)
(Supplementary Fig. 3a). Similarly, Cas9 ± λRed induction with
aTc or arabinose, respectively, did not appreciably impact
overnight culture densities under triple-antibiotic selection
(Supplementary Fig. 3b).
Pro-AG efficiently inactivates antibiotic resistance. As an initial
comparison between the CRISPR-control (Fig. 1a) and the Pro-
AG (Fig. 1c) configurations, overnight cultures of E. coli colo-
nies transformed with the corresponding three-plasmid systems
were grown in triple antibiotics with or without aTc (to induce
Cas9), alone or in combination with arabinose (to induce λRed
enzymes), then plated for CFU enumeration (Fig. 1d). In con-
trast to ~ 100-fold CFU reduction observed with the gRNA
using our “CRISPR-control” component configuration (Fig. 1b,
d), targeting of bla using the Pro-AG format (i.e., induction of
Cas9+ λRed) led to a ~ 100,000-fold reduction in AmpR CFU
(Fig. 1d). For reasons that remain unclear, induction of λRed
also yielded a modest reduction in CFU recovery in the
CRISPR-control regimen; however, this effect was much more
pronounced in a Pro-AG context (Fig. 1d, green vs. blue
shading). The intensified reduction in AmpR E. coli CFU could
not be attributed to secondary effects of aTc and/or Cas9
induction, since no significant differences in CFU were
observed under Amp selection (+ Amp) without Cas9 induc-
tion (–aTc) compared with Cas9 induction (+ aTc) without
Amp selection (–Amp) (Supplementary Fig. 4a). Additional
controls excluded suppressive effects of arabinose or λRed
enzyme expression per se, as arabinose induction alone did not
alter CFU recovery (Supplementary Fig. 4b).
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We expected that either unrepaired CRISPR-mediated double-
stranded DNA breaks or potential Pro-AG-mediated insertion of
gRNA2 sequences into the corresponding cleavage site would
inactivate the bla target gene, and therefore that E. coli
undergoing such events would not be viable upon selection for
AmpR. Indeed, among the few AmpR colonies recovered
following either CRISPR-control (green box) or Pro-AG (blue
box) treatments (i.e., induction of Cas9+ λRed), sequence
analysis showed that 100% (30/30) carried unaltered pET
plasmids with intact bla gene-coding sequences at the gRNA
target site (Fig. 1d, bottom panel). These rare examples of AmpR
E. coli colonies that evaded CRISPR or Pro-AG editing, likely
from incomplete target cleavage of the high copy number
plasmid, are referred to hereafter as “escapers”.
Pro-AG results in precise homology-mediated editing. In ana-
logy to HDR-dependent copying of gene-drive elements in diploid
organisms, enhanced gene targeting activity of Pro-AG over
CRISPR-control (Fig. 1d) might reflect homology-mediated
insertion of the gRNA cassette into the bla gRNA2/Cas9 clea-
vage site. We tested this hypothesis by incorporating a second
selectable antibiotic resistance gene (gentamicin—GmR) into the
target pET plasmid (pETg; Supplementary Table 1), allowing
recovery of bla gene-edited plasmids by selection on Gm plates
(Supplementary Fig. 1). Consistent with high efficiency insertional
copying, virtually the entire decrement of CFU seen in Pro-AG vs.
CRISPR-control systems under Cas9+ λRed induction and AmpR
selection could be recovered under GmR selection (Fig. 2a, blue
box). Likewise, as expected, all Pro-AG recovered GmR colonies
failed to grow on Amp plates (Fig. 2b, bottom panel). In contrast
to the nearly full restoration of the λRed-induced CFU decrement
observed upon GmR selection with the Pro-AG regimen, no CFU
recovery was observed under GmR vs. AmpR selection using the
CRISPR-control protocol for targeting bla (Fig. 2a, green box).
a CRISPR
CRISPR
AmpR escapers analysis
AmpgRNA2
Pro-AG
Pro-active genetics (Pro-AG)
E.
 
co
li 
M
G
16
55
 
E.
 
co
li 
M
G
16
55
 
pET
pET
Target
Target
PAM
PAM
PAM
30/30
30/30
PAM
AmpR
gRNA
gRNA1
NS
– aTC10
9
8
7
6
Lo
g 1
0C
FU
/m
l
Lo
g 1
0C
FU
/m
l
5
10
9
8
7
6
5
4
3
+ aTC
– aTC
+ aTC
 aTC
arab+
gRNA2
gRNA1 gRNA2
gRNA2
Cas9
cut site
Cas9
cut site
3′
3′
5′
5′
Cas9 cut sites
aTC
aTCHA2HA1
Arab
Red
Red
λRed
HA1 HA2
SpmR
SpmR
pCRISPR
Amp
pPro-AG
Amp
AmpR
AmpR
AmpR
Cas9
Cas9
CmR
CmR
ca
s9
ca
s9
pCas9
pCas9
b
c
d
Fig. 1 Pro-active genetics (Pro-AG) is ~ 100× more efficient than CRISPR-control for targeting antibiotic resistance conferred by a high copy plasmid.
a and c Schematic of CRISPR-control- a and Pro-AG- c mediated editing of beta-lactamase gene (bla) encoded on a high copy plasmid (pET) conferring
resistance to ampicillin (AmpR, tan arrow) in E. coli MG1655. gRNAs were initially expressed from a low copy plasmid (pCRISPR Amp) maintained under
spectinomycin (Spm) selection and using the constitutive tet promoter to express the gRNA. A second low copy plasmid, pCas9, maintained under
chloramphenicol (CmR) selection, encodes Cas9 under control of an anhydrotetracycline (aTc) inducible promoter. a CRISPR-control configuration: two
gRNAs (gRNA1 and gRNA2 carried on the pCRISPR Amp plasmid) were tested for Cas9-mediated targeting at two different locations in the bla gene. The
Cas9/gRNA1 and Cas9/gRNA2-induced cleavage sites, and the protospacer adjacent motif (PAM) are indicated as well as a gene cassette carrying the
λRed enzymes. b Recovery of AmpR colony-forming units (Log10CFU/ml) following CRISPR-mediated targeting of the bla gene with gRNAs 1 or 2 in the
absence (− aTc, black dots) or presence (+ aTc, blue dots) of aTc-induced Cas9 expression. c Pro-AG configuration: the gRNA2 expression cassette
flanked by bla (AmpR) homology arms (HA1 and HA2) that directly abut the gRNA2 cleavage site was incorporated into pCRISPR Amp. The Cas9/gRNA2-
induced cleavage site, the protospacer adjacent motif (PAM), and the HA1 (dark yellow box), and HA2 (light yellow box) homology arms are indicated.
Also carried on plasmids pCRISPR Amp and pPro-AGAmp are the recombinogenic λRed enzymes (λRed), which can be induced with L-arabinose (arab).
d Recovery of CFU on Amp plates following CRISPR-control versus Pro-AG-mediated targeting of the bla gene. In this and subsequent panels, abbreviations
for Cas9 induction are as in panel b; induction of λRed enzymes: (+ aTc+ arab: red dots); CRISPR (green shaded box) and Pro-AG (blue shaded box)
treatments are highlighted. Plasmids sequenced from AmpR colonies (CRISPR, green box and Pro-AG, blue box) displayed unaltered gRNA target sites in
all clones analyzed (30/30). Data in b and d are plotted as the mean ± SEM, representing three independent experiments performed in triplicate and
analyzed by Student’s t test. N.S.= not significant (P > 0.05) *P < 0.05; **P < 0.01; ****P < 0.0001. Source Data are available in the Source Data file.
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A clear prediction of the Pro-AG hypothesis examined above is
that all recovered GmR colonies should carry a precise insertion of
the gRNA expression cassette. Indeed, analysis of 30 Gm-selected
pETg plasmids from Pro-AG single colonies confirmed that the
DNA cassette carried between the two homology arms, including
the full gRNA2 scaffold and its promoter (Fig. 2c, bottom
scheme), were perfectly copied from the donor plasmid (pPro-
AGAmp, Fig. 1c; Supplementary Table 1) into the gRNA2 clea-
vage site of the bla target gene in all clones (Fig. 2c, blue circle).
Thus the function of the targeted bla gene is disrupted by insertion
of the gRNA expression cassette within its protein coding region.
In contrast, all CRISPR-control-treated unedited E. coli escaper
colonies recovered on GmR selection regrew under selection for
AmpR (Fig. 2b, top panel). Consistent with such escapers having
evaded CRISPR-mediated mutagenesis, all (30/30) examined
AmpR+GmR CRISPR escapers displayed intact (unedited) bla
gRNA2 target sites (Fig. 2c, green circle). In aggregate, the above
findings support the hypothesis that the greatly enhanced reduc-
tion of AmpR CFU observed upon Pro-AG versus CRISPR-control
editing configurations is quantitatively attributable to homology-
mediated insertion of gRNA2 sequences into bla-coding sequences
on the target pETg plasmid. Of note, each insertional editing event
expands the pool of functional gRNA donor scaffolds with
extended homology arms in their newly copied plasmid context,
which may initiate a chain reaction accelerating further insertional
events.
As mentioned above, E. coli “escaper” colonies that evaded Pro-
AG editing showed intact target sequences (Fig. 1d, bottom panel).
We hypothesized that inefficient Cas9 cleavage in escaper cells
could reflect competition with the bacterial DNA repair system.
We tested this idea by comparing Pro-AG editing of the bla gene
target carried by the pETg plasmid in WT vs. ΔrecA E. coli
(Supplementary Fig. 1b). A significant reduction of AmpR CFUs
was obtained in ΔrecA cells, under Cas9 induction alone or in
combination with λRed (Supplementary Fig. 5a). All target
plasmids analyzed from both GmR WT and ΔrecA E. coli colonies
bore precise gRNA2 insertions into bla target gene (Supplementary
Fig. 5b), paralleling the editing efficiencies observed in previous
experiments (Fig. 2c). Although these findings indicate that RecA
is not required for copying the gRNA2 expression cassette from
donor plasmid to target gene, they also suggest that Pro-AG
escaper cells are partially protected in a RecA-dependent manner.
An additional previously observed mechanism of escape from
CRISPR-Cas9-mediated editing of E. coli involves mutations in the
gRNA-harboring plasmid8,10. Consistent with similar mechanisms
operating in CRISPR-based editing experiments, analysis of the
pPro-AG (Amp) plasmid from escaper cells revealed that ~ 50% of
gRNA launching plasmids recovered from escaper lines harbored
deletions spanning the operator region, the gRNA and/or the
gRNA scaffold sequences (Supplementary Fig. 6a).
Pro-AG depends on homology sequences flanking the gRNA.
The above-described Pro-AG configuration, wherein the gRNA
expression cassette is flanked directly by homology arms, repre-
sents the minimal possible self-copying element. We wondered if
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Fig. 2 Efficient reduction of AmpR CFU by Pro-AG results from homology-mediated insertion of active gRNA cassettes into the bla target gene.
a Selection for E. coli CFU on ampicillin (Amp, filled dots) or gentamicin (Gm, open dots) plates following CRISPR-control- or Pro-AG-mediated targeting of
the dual antibiotic-resistant target plasmid pETg (see pETg plasmid schematic in c from single colonies grown in the presence (+ aTc, blue dots), in the
absence (−aTc, black dots) of anhydrotetracycline for induction of Cas9, or in combination of aTc and arabinose (+ aTc+ arab, red dots) for induction of
Cas9 and λRed, respectively. b Individual colonies isolated from gentamicin plates following Cas9 and λRed induction under CRISPR (green shaded box) or
Pro-AG (blue shaded box) regimens in a were streaked on new ampicillin (AmpR, left images) and gentamicin (GmR, right images) plates. Representative
images of 200 colonies struck from CRISPR-control (top) or Pro-AG (bottom) are shown. c DNA sequence analysis of plasmids isolated from single
colonies in b recovered from either the CRISPR-control regimen (AmpR or GmR plates; green arrow) or the Pro-AG regimen (GmR plates; blue arrow). All
30 CRISPR-derivative clones analyzed revealed a fully intact pETg plasmid (unedited, green circle), whereas all 30 Pro-AG-derivative clones analyzed
carried a perfect insertion of the homology-flanked gRNA2 expression cassette into the bla gene (zoom-in bottom scheme). The gRNA expression cassette
is composed of the gRNA scaffold (purple), 20 bp gRNA-targeting sequences (pink and black), and the constitutive tet promoter (gray). Also indicated are
the Cas9 cleavage site, and homology arms (HA1, dark yellow box and HA2, light yellow box) that flank the gRNA2 cleavage site in the bla target gene
carried on the pETg plasmid. Data in a are plotted as the mean ± SEM, representing three independent experiments performed in triplicate and analyzed by
Student’s t test. N.S.= not significant (P > 0.05) *P < 0.05. Source Data are available in the Source Data file.
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this system might also be exploited to deliver additional DNA
cargo sequences efficiently. As a test case, a green fluorescence
protein (GFP) transgene was included as cargo with the gRNA2
expression cassette between the bla gene homology arms (pPro-
AGFPAmp, Fig. 3a, Supplementary Table 1). Using the same
experimental design described above for targeting AmpR+GmR
plasmid pETg with the “gRNA-only” pPro-AG plasmid (Fig. 3a),
the cargo-laden pPro-AGFP construct performed similarly to its
minimal counterpart in reducing AmpR CFU versus the CRISPR-
control regimen (Fig. 3b). As for the minimal Pro-AG element,
regrowth of single Pro-AGFP colonies recovered on Gm plates
following Cas9+ λRed induction (Fig. 3b, blue box) revealed
perfect insertion of the composite gRNA2:GFP cassette into the
bla gRNA2 cleavage site in 100% of clones analyzed (Fig. 3c, blue
circle). Again, escaper colonies recovered under the CRISPR-
control regimen on Gm plates with Cas9+ λRed induction
(Fig. 3b, green box) maintained pristine unedited gRNA target
sequences and also displayed an AmpR phenotype (Fig. 3c, green
circle). We conclude that the Pro-AG system leads to highly
efficient and precise insertion of the gRNA2:GFP cargo bearing
cassette into the gRNA2 bla gene target site.
A defining feature of self-amplifying CRISPR-based gene-drive
systems in diploid organisms is insertion of the gRNA-bearing
cassette at the exact genomic site where the gRNA directs target
cleavage17. If amplification of the gRNA gene dosage resulting
from its being actively copied contributed to the enhanced
efficiency of the Pro-AG system, then placement of the gRNA
outside of the homology arm cassette (pgRNAOut-Amp) (Fig. 3a,
Supplementary Table 1) would significantly reduce editing
efficiency of the target plasmid. Indeed, the gRNA-Out config-
uration performed comparably to the CRIPSR-control protocol,
leading only to an ~ 3 log10-fold reduction in CFU under AmpR
selection and Cas9+ λRed+ induction (Fig. 3b). Thus, the entire
boost in AmpR CFU reduction provided by the Pro-AG system
was abrogated by placing the gRNA outside of the homology
arms, consistent with the hypothesis that the Pro-AG process acts
via a positive feedback amplification mechanism (Fig. 3b).
Although the gRNA-out configuration eliminated the ~ 2-log
increment in CFU reduction observed with Pro-AGFP arrange-
ment under AmpR selection, significant CFU recovery was
nonetheless observed upon GmR selection, suggesting that a
large fraction of the baseline DNA breaks induced by CRISPR-
control conditions were now being repaired by precise copying of
the homology-flanked GFP-only cassette. Indeed, all 20 plasmids
analyzed from GmR colonies under the gRNA-Out regimen
(Fig. 3b, red bar) carried perfect insertions of the GFP-only
cassette within the gRNA2 cleavage site of bla (Fig. 3c, red circle).
Amplification of the gRNA contributes to Pro-AG perfor-
mance. As copying of the gRNA2 expression cassette from a low
(pPro-AG) to a high copy number plasmid (pETg) significantly
amplified gRNA gene number and hence expression levels, we
wondered whether the enhanced performance of Pro-AG versus
CRISPR-control could be wholly attributable to this effect. We
addressed this question by comparing AmpR CFU reduction
using CRISPR-control versus Pro-AG configurations in a situa-
tion where the bla-targeting gRNA2 was encoded from the outset
on a high copy number plasmid, namely the pETg target plasmid
itself, which would limit gRNA amplification to at most twofold.
E. coli harboring pCas9 and pΔgRNA (Supplementary Table 1)
expressing Cas9 and λRed, respectively, were transformed with
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Fig. 3 The Pro-AG system mediates efficient editing and cargo delivery dependent on precise flanking of the gRNA cassette by homology arms of the
target gene. a Schematic of plasmids used to compare performance of CRISPR-control (pCRISPR Amp), Pro-AGFP (pPro-AGFPAmp: gRNA2+GFP within
homology arms), and external placement of gRNA2 outside of the homology arms flanked cassette (pgRNA Out-Amp: GFP-only within homology arms,
gRNA outside of HA-cassette). b Recovery of E. coli CFU following CRISPR-control or Pro-AG using the three different plasmid configurations indicated in a
and the various induction conditions indicated in the key. c Sequence analysis of targeted plasmids. pETg plasmids recovered from CRISPR-control-treated
colonies (green circle) all display intact target sequence (“escapers”). Analysis of all Pro-AGFP-recovered pETg plasmids (blue circle) confirmed precise
insertion of the gRNA+GFP cassette at the gRNA cut site, which consists of the full gRNA cassette (scaffold, purple; gRNA, pink and black, and tet
promoter, gray) plus GFP. Although the gRNAOut-targeted pETg configuration (red circle) resulted in ~ 100-fold less efficient targeting of the bla target
gene than the Pro-AGFP configuration, all plasmids isolated from colonies selected on Gm plates carried precise insertions of the GFP-only cassette. Data
in b are plotted as the mean ± SEM, representing three independent experiments performed in triplicate and analyzed by Student’s t test. N.S.= not
significant (P > 0.05); ***P < 0.001; ****P < 0.0001. Source Data are available in the Source Data file.
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either pETgCRISPR or pETgPro-AG plasmids (Supplementary
Fig. 7a, Supplementary Table 1). Using our earlier CRISPR-
control and Pro-AG-editing protocols under Amp selection
(Supplementary Fig. 1), Pro-AG performed 1-logfold more effi-
ciently than CRISPR-control in reducing AmpR CFUs (Supple-
mentary Fig. 7b). Although this Pro-AG gain is less than that
achieved when gRNA2 was launched from a low copy plasmid,
where we observed 2-logfold improved efficiencies, this more
modest enhancement suggests that the full Pro-AG effect is not
solely attributable to copy number amplification of gRNA2
(Fig. 1d). As before, significant CFU recovery occurred on Gm
plates following Pro-AG editing (Supplementary Fig. 7b, top
panel, blue shading), with perfect insertions of gRNA cassette into
bla-coding sequences in 100% of pETgPro-AG plasmids analyzed
(Supplementary Fig. 7b, bottom panel). We conclude that
amplification of the homology-flanked gRNA, which may repli-
cate itself ~ 50 times in a high copy plasmid, contributes sig-
nificantly to the enhanced performance of Pro-AG. Additional
mechanisms such as increased homology sequence length and
double-strand DNA break repair may also contribute to enhanced
Pro-AG efficiency compared with CRISPR only controls.
Pro-AG acts via a self-amplifying mechanism. As yet another
approach to assess the role of cassette amplification in the
enhanced performance of Pro-AG versus CRISPR-control para-
digms we made use of the temperature sensitive nature of repli-
cation of the low copy number gRNA2 donor plasmids. Switching
overnight growth cultures from 30 °C (permissive temperature for
plasmid replication) to 37 °C (non-permissive temperature)
during the editing protocol reduced SpmR CFU that harbor the
gRNA2 plasmid by ~ 2.5-logfold (Supplementary Fig. 8a). As in
previous experiments, Amp selection produced a significant
reduction of AmpR CFUs for both CRISPR-control and Pro-AG
configurations following Cas9 and λRed induction (+ aTc+
arab) at 30 °C, which was more pronounced for Pro-AG. In
contrast, only the Pro-AG regimen, and not CRISPR-controls,
also reduced AmpR CFUs following Cas9+ λRed induction
(+ aTc+ arab) at 37 °C (Supplementary Fig. 8b). Based on these
several independent lines of corroborating evidence, we conclude
that incorporating the gRNA (± cargo) between homology arms
to generate the active genetic cassette greatly increases targeting
efficiency of a high copy number plasmid via a self-sustaining
positive feedback loop.
Pro-AG is amenable to manipulation of large plasmids. Large
plasmids carried by various pathogens pose an important health
problem and are challenging to manipulate by traditional meth-
ods. We wondered whether the enhanced Pro-AG system might
again offer advantages in such a context. We chose an E. coli
strain harboring the pCas9 plasmid and a ~ 50 Kb cosmid vector
(Supercos SV305, Supplementary Table 1) carrying Amp and Km
selection markers as a test case. As in previous experiments, cells
were transformed with either the pCRISPR Amp control or pPro-
AG (SuperCos) plasmids, the latter adopting a Pro-AG config-
uration to target the bla gene encoded on the cosmid (Supple-
mentary Fig. 9a). Following our standard editing protocols
(Supplementary Fig. 1), we observed a 1-logfold greater reduction
in AmpR CFUs with the Pro-AG regimen than CRISPR-control
following Cas9 and λRed induction (+ aTc+ arab) (Supple-
mentary Fig. 9b, top panel). Indicative of Pro-AG-mediated
double-strand DNA break repair, significant CFUs were rescued
under Km selection (Supplementary Fig. 9b, top panel, blue
shading box), and 100% of the Supercos SV305 cosmids isolated
and sequenced showed a precise gRNA cassette insertion into bla
(Supplementary Fig. 9b, bottom panel). Thus Pro-AG is well
suited for gene editing large multi-copy plasmids, with efficient
homology-mediated insertion of gRNA sequences into the tar-
geted coding region.
CRISPR and Pro-AG are equivalent for single locus editing.
Given its efficiency in meeting the challenging task of targeting a
high and moderate copy number plasmids, we asked whether the
Pro-AG approach could similarly be employed to insert gRNA-
only or gRNA+GFP cargo cassettes into a single-copy chro-
mosomal target (e.g., the lacZ gene). We found that Pro-AG
configurations indeed performed with high efficiency in this
context as well (Supplementary Text and Supplementary Figs. 10
and 11). Because in this context there is no need for cassette
amplification provided by Pro-AG, we predicted that targeting
efficiency would not depend on the placement of the gRNA
between homology arms. This expectation was confirmed by
experiments in which the gRNA was placed between (gRNA-in)
or outside (gRNA-out) of the GFP-containing cassette since both
configurations performed equivalently in precise editing of the
lacZ target gene (Supplementary Fig. 12).
Discussion
Cumulatively, our results indicate that the Pro-AG configuration
is 2–3 orders of magnitude more efficient in disrupting the
activity of a high copy number target gene (bla) than the CRISPR-
control arrangement, yielding to a 4–5 log10-fold reduction in
AmpR E. coli, fully attributed to precise insertion of the gRNA
(± cargo) cassette from the editing vector into the targeted gRNA
cleavage site. Increased potency of the Pro-AG versus CRISPR-
control configuration in reducing antibiotic-resistant CFUs
depends on the gRNA cassette being precisely flanked by bla
homology arms, suggesting that an amplifying positive feedback
loop occurs from increasing gRNA copy number, a potential rate-
limiting component of the system. The high efficiencies of
accurate Pro-AG cassette copying in bacteria are comparable to
those attained by gene-drive systems in diploid organisms
(> 90%)1–3,18. In addition to its high efficiency, Pro-AG maintains
an ability to perform precise and potentially subtle edits of a
target gene rather than simply eliminating the target sequence or
bacteria carrying that locus.
Multiple genome-engineering applications could ultimately
benefit from incorporation of the Pro-AG platform, including
elimination of bacterial virulence factors carried by diverse
episomal elements and resistance determinants in commensal
bacteria as well as different prokaryotic pathogens, scrubbing
antibiotic resistance genes from bacteria in the environment19,
livestock, inland fish farms, or sewage treatment ponds20,
reprogramming genetic circuits impacting bacterial physiology, or
tailoring interactions among the microbiota in environmental or
host niches. For each of these applications suitable delivery sys-
tems such as phage vectors21 or conjugative plasmids22 would
need to be developed and tailored to the specific contexts in
which they were being deployed.
Methods
Strains and culture conditions. E. coli strain MG1655 WT and ΔRecA were
provided by the B. Palsson and Susan Lovett Laboratories, respectively. Liquid
cultures of E. coli were grown in LB medium. When appropriate, antibiotics were
added as following: chloramphenicol (Cm, 25 μg/ml), ampicillin (Amp, 100 μg/ml),
spectinomycin (Spm, 50 μg/ml), and gentamicin (Gm, 10 μg/ml).
Plasmid construction. All constructs used in this study are listed in Supple-
mentary Table 1 with primer sequences provided in Supplementary Table 2.
Plasmids pKDsgRNA (pCRISPR) and pCas9-CR4 (pCas9) (Table S1) were pur-
chased from Addgene (Cambridge, MA). pCRISPR(AmpgRNA1), pCRISPR
(AmpgRNA2) and pCRISPRlacZ were built as previously described9. The 20 bp
targeting sequences of the gRNAs were cloned into pKDsgRNA using circular
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polymerase extension cloning (CPEC)23 of two linear PCR fragments (F1, 3 kb; F2,
4 kb). For pCRISPR(AmpgRNA1) (Supplementary Table 1), F1 and F2 were
obtained using the paired primers 13_FwAmpgRNA1/14_RvF1 and 15_FwF2/
16_RvAmpgRNA1 (Supplementary Table 2), respectively. For pCRISPR
(AmpgRNA2) (Supplementary Table 1), F1 and 1 and 2 were obtained using the
paired primers 17_FwAmpgRNA2 /14_RvF1 and 18_RvAmpgRNA2 /15_FwF2
(Supplementary Table 2), respectively. For pCRISPRlacZ (Supplementary
Table 1), F1 and F2 were obtained using the paired primers 33_FwlacZgRNA/
14_RvF1 and 34_RvlacZgRNA/15_FwF2 (Supplementary Table 2), respectively.
PCR products with ~ 280 bp of overlapping homology sequences and 20 bp of
overlap in the protospacer region were DpnI digested for at least 15 min then gel-
purified. Fragments 1 and 2 were mixed together in equal amounts (200 ng each)
and CPEC cloned with 15 cycles and Phusion High-Fidelity Polymerase (NEB). In
all, 2.5 μl of the mixture was used to transform one-shot Stbl3 chemically com-
petent E. coli cells (Thermo Fisher).
Plasmids expressing Pro-AG configurations pPro-AG(Amp), pPro-AG(lacZ),
and pPro-AG Super-Cos (Supplementary Table 1) were built in two Gibson
(NEBuilder, NEB) assembly steps using two linear PCR fragments with flanking
overlapping sequences. For the pPro-AG(Amp) plasmid construct, the first step
consisted of cloning bla sequence homology arm 1 in pCRISPR(AmpgRNA2) to
generate the plasmid pCRISPR(AmpgRNA2+HA1) (Supplementary Table 1) by
amplification of two PCR fragments (F1 and F2) with paired primers 37_FwgRNA2/
38_RvgRNA2 and 39_FwHA1Amp/40_RvHA1Amp (Supplementary Table 2),
respectively. A second step consisted of cloning bla sequence homology arm 2
in pCRISPR(AmpgRNA2+HA1) to generate plasmid pPro-AG(Amp)
(Supplementary Table 1) by amplification of two PCR fragments (F1 and F2) with
paired primers 41_FwgAmpHA1/42_RvgAmpHA1 and 43_FwHA2/44_RvHA2
(Supplementary Table 2), respectively. For the pPro-AG(lacZ) plasmid construct, a
first step consisted of cloning lacZ sequence homology arm 1 in pCRISPR(lacZ) to
generate pCRISPR(lacZ+HA1) plasmid (Supplementary Table 2) by amplification
of two PCR fragments (F1 and F2) with paired primers 51_FwlacZgRNA/
52_RvlacZgRNA and 53_FwHA1lacZ/54_RvHA1lacZ (Supplementary Table 2),
respectively. A second step consisted of cloning lacZ sequence homology arm 2
in pCRISPR(lacZ+HA1) to generate plasmid pPro-AG(lacZ) (Supplementary
Table 1) by amplification of two PCR fragments (F1 and F2) with paired
primers 55_ FwlacZHA1/56_FwlacZHA1 and 57_FwlacZHA2/58_RvlacZHA2
(Supplementary Table 2), respectively. For the pPro-AG Super-Cos plasmid
construct, we first cloned bla sequence homology arm 1 in pCRISPR
(AmpgRNA2) to generate the plasmid pCRISPR(AmpgRNA2+ SV3B05HA1HA1)
(Supplementary Table 1) by amplification of two PCR fragments (F1 and F2)
with paired primers 106_FwHA1Supercos/107_RvHA1Supercos and
108_FwpKDsAmp2/109_RvpKDsAmp2 (Supplementary Table 2), respectively. A
second step consisted of cloning bla sequence homology arm 2 in pCRISPR
(AmpgRNA2+ SV3B05HA1HA1) to generate plasmid pPro-AG Super-Cos
(Supplementary Table 1) by amplification of two PCR fragments (F1 and F2) with
paired primers 110_Fw HA2Supercos/111_Rev HA2Supercos and Pr_112Fw
CosHA1/Pr_113Rv CosHA1 (Supplementary Table 2), respectively.
Plasmids pETg, pPro-AGFP(Amp), pPro-AGFP(lacZ), pETgCRISPR, and
pETgPro-AG (Supplementary Table 1) were generated by amplification of two
linear PCR fragments (F1 and F2), with flanking overlapping sequences for Gibson
assembly (NEBuilder, NEB). Paired primers 59_FwpET/60_RvpET and 61_FwGm/
62_RvGm (Supplementary Table 2) were used to amplify PCR F1 and F2 to
assemble pETg. Paired primers 69_FwP-AG(Amp)/73_RvP-AG(Amp) and
72_FwGFP-Amp/68_RvGFP-Amp (Supplementary Table 2) were used to amplify
PCR F1 and F2 to assemble pPRO-AGFP(Amp). Paired primers 63_FwP-AG(lacZ)/
64_RvP-AG(lacZ) and 65_FwGFP-lacZ/66_RvGFP-lacZ (Supplementary Table 2)
were used to amplify PCR F1 and F2 to assemble pPro-AGFP(lacZ). Paired primers
98_FwProAG/99-RvPro-AG and 100_FwpETg(Pro-AG)/101_RvpETg(Pro-AG)
were used to amplify PCR F1 and F2 to assemble pETgCRISPR. Paired primers
102_FwCRISPR/103-RvCRISPR and 104_FwpETg(CRISPR)/105_RvpETg(CRISPR)
were used to amplify PCR F1 and F2 to assemble pETgCRISPR.
For the pgRNAout (Amp) and pgRNAout (lacZ) plasmid constructs, pCRISPR
(AmpgRNA2) and pCRISPR(lacZ), respectively were linearized with the NcoI
restriction enzyme. Subsequently, three fragments with flanking overlapping
sequences (F1, F2, and F3) were PCR amplified as follows. For pgRNAout (Amp)
construct, homology arms 1 (F1) and 2 (F2) from pPro-AG(Amp) and gfp (F3)
from plasmid #48138 (Addgene), using primer pairs 67_FwHA1-GFPout/
68_RVHA1-GFPout, 69_FwHA2-GFPout/70_RvHA2-GFPout and 71_FwGFP-
GFPout/72_RvGFP-GFPout (Supplementary Table 2), respectively. For pgRNAout
(lacZ) construct, homology arms 1 (F1) and 2 (F2) from pPro-AG(lacZ) and gfp
(F3) from plasmid #48138 (Addgene), using primer pairs 88_FwHA1-lacZout/
89_RvHA1-lacZout, 92_FwHA2-lacZout/93_RvHA2-lacZout and 90_FwGFP-
lacZout/91_RvGFP-lacZout (Supplementary Table 2), respectively. Gibson
assembly was carried out with the linearized vectors and the three corresponding
overlapping PCR fragments to generate pgRNAout(Amp) and pgRNAout(lacZ)
(Supplementary Table 1). All Gibson assembly reactions were transformed into
NEB 5-alpha competent E. coli cells.
E. coli transformation. Competent cells were prepared as previously described
(Short Protocols in Molecular Biology, Chapter 1). For all plasmid transformations,
50 μl of aliquoted cells were gently thawed on ice, followed by addition of plasmid
DNA prepared by QIAprep Spin Miniprep Kit (Qiagen), with 20 ng of each
plasmid added to the transformation mix. E. coli cells were electroporated with the
1 mm Gene Pulser cuvette (Bio-Rad) at 1.6 kV and immediately resuspended in
250 μl super optimal broth with catabolite repression media. Cells were allowed to
recover for 2 h at 30 °C (for cells transformed with pKDsgRNA derived plasmids)
and for 1 h at 37 °C for cells transformed with pETg plasmid. Serial dilutions of
cells were plated on LB with the corresponding antibiotic and they were incubated
at 30 °C (48 h) or 37 °C (24 h), respectively.
Induction of Cas9 and Lambda-Red enzymes. Single E. coli colonies obtained on
plates after transformation were resuspended in 60 μl LB, which served as inocu-
lum for 5 ml LB overnight cultures (~ 15 h) grown at 30 °C with shaking (200 rpm).
When appropriate, Cas9 expression was induced in cells carrying the pCas9
plasmid (Supplementary Table 1) by adding 100 ng/ml anhydrotetracycline (aTc,
Abcam) to the broth media. Similarly, when desired, λ-Red expression was induced
in cells carrying pKdsgRNA derivative plasmids (Supplementary Table 1) by
adding 50 mM arabinose (arab, Sigma) to the broth media during editing steps
(Supplementary Fig. 1).
E. coli colony counts. CFU were determined similarly to the miniaturized plating
method described previously with small modifications. In brief, 25 μl of overnight
culture, and dilution series of 10−1 to 10−8, were spotted in triplicate on LB plates
containing the appropriate antibiotic selection and incubated overnight at 30 °C.
No notable differences were observed when arab or aTc were added to the plates
for λ-Red or Cas9 induction, respectively.
Sequence analysis of editing events. For bla-editing events, pETg plasmids and
Super-Cos (SV3B06) cosmids were purified from AmpS/GmR AmpS/KmR,
respectively, single edited E. coli colonies by QIAprep Spin Miniprep Kit (Qiagen)
and sequenced (Genewiz) with primer 35_FwAmp(ext) (Supplementary Table 2).
pET-derivative plasmids from single escapers were analyzed following the same
parameters. For lacZ-editing events, white E. coli colonies where quantified among
the total white+ blue mixed population of colonies on LB plates containing 1 mM
IPTG and 0.03 % (v/v) Bluo-Gal (Teknova). Single white colonies were grown
overnight at 37 °C and total genomic DNA isolated by DNeasy Blood and Tissue
(Qiagen). PCR products were obtained with Q5 DNA polymerase (NEB) and using
primer pairs 49_FwlacZseq and 50_RvlacZseq, followed by sequencing analysis
(Genewiz) with primer 63_RvlacZint (Supplementary Table 2). Escaper blue
colonies were also analyzed following the same parameters. gRNA plasmid con-
structs from escapers were sequenced with primers 27_Fw pKDSgRNAseq and
28_Rv pKDSgRNAseq.
Visualization and quantification of GFP expression. In all, 10 μl aliquots from
overnight cultures of E. coli exposed to the Pro-AGFP configuration in LB+
1 mM IPTG and under Cas9 and λ-Red induction were mounted onto slides with
coverslips. GFP fluorescence was visualized using a Zeiss Axio Observer.D1
fluorescence microscope. For GFP fluorescence quantification, single white
colonies from E. coli lacZ-editing plates were homogenized in 200 μl PBS and
subsequently transferred to a 96-well plate. Optical density at 600 nm and GFP
fluorescence at 510 nm were measured by using an EnSpire Plate Reader
(PerkinElmer).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated and analyzed during this study are included in the published article or
provided in the Supplementary Information and are available from the corresponding
author upon request. Source Data for Figs. 1–3 and Supplementary Figures 2–5, 7–12 are
available in the Source Data file.
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